Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
$7.20
-3.0%
$4.20
$2.20
$12.53
$6.92BN/A4.22 million shs5.75 million shs
Atos SE stock logo
AEXAY
Atos
$0.38
$0.44
$0.34
$3.28
$211.74M1.256,332 shsN/A
ANA Holdings Inc. stock logo
ALNPY
ANA
$4.01
+1.3%
$4.19
$3.76
$4.93
N/A0.54,821 shs620 shs
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$11.91
+0.7%
$11.98
$9.54
$13.20
$6.32B1.4310,698 shs16,645 shs
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$22.33
$24.11
$21.28
$27.15
$4.92B0.5149 shsN/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
+14.65%+22.03%+48.15%+1,765.28%+1,105.63%
Atos SE stock logo
AEXAY
Atos
0.00%-5.00%-2.46%-59.14%-84.46%
ANA Holdings Inc. stock logo
ALNPY
ANA
+1.26%+4.16%-6.09%-7.39%-7.28%
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
+0.68%+2.50%-0.92%-3.68%+10.58%
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
0.00%-7.92%-4.45%-8.95%+8.19%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
N/AN/AN/AN/AN/AN/AN/AN/A
Atos SE stock logo
AEXAY
Atos
N/AN/AN/AN/AN/AN/AN/AN/A
ANA Holdings Inc. stock logo
ALNPY
ANA
N/AN/AN/AN/AN/AN/AN/AN/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
N/AN/AN/AN/AN/AN/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
N/AN/AN/AN/A
Atos SE stock logo
AEXAY
Atos
2.00
HoldN/AN/A
ANA Holdings Inc. stock logo
ALNPY
ANA
3.00
BuyN/AN/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
1.50
ReduceN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
2.00
HoldN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
N/AN/AN/AN/AN/AN/A
Atos SE stock logo
AEXAY
Atos
$11.57B0.02$1.52 per share0.25$0.12 per share3.17
ANA Holdings Inc. stock logo
ALNPY
ANA
$12.64BN/A$0.03 per share123.18N/AN/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$3.06B2.06$1.08 per share11.04$7.44 per share1.60
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$2.88B1.71$3.33 per share6.71$10.03 per share2.23

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
N/A$0.1260.00N/AN/AN/AN/AN/A
Atos SE stock logo
AEXAY
Atos
-$3.72BN/A0.00N/AN/AN/AN/AN/A
ANA Holdings Inc. stock logo
ALNPY
ANA
$662.13M$0.488.35N/A8.73%18.17%4.89%N/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$559.54MN/A0.0012.95N/AN/AN/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$190MN/A0.0010.20N/AN/AN/AN/AN/A

Latest BKGFY, HKMPF, ALNPY, ACBFF, and AEXAY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
1/31/2024Q3 2024
ANA Holdings Inc. stock logo
ALNPY
ANA
N/A$0.14+$0.14$0.14N/A$3.66 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
N/AN/AN/AN/AN/A
Atos SE stock logo
AEXAY
Atos
N/AN/AN/AN/AN/A
ANA Holdings Inc. stock logo
ALNPY
ANA
N/AN/AN/AN/AN/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$0.151.26%N/AN/AN/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$0.944.21%N/AN/AN/A

Latest BKGFY, HKMPF, ALNPY, ACBFF, and AEXAY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/6/2024
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
$0.473/20/20243/22/20245/3/2024
3/1/2024
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$0.07363/8/20243/11/20244/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
N/AN/AN/A
Atos SE stock logo
AEXAY
Atos
41.48
0.92
0.92
ANA Holdings Inc. stock logo
ALNPY
ANA
1.28
1.71
1.65
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
0.19
3.57
0.64
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
0.47
1.57
0.90

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
N/A
Atos SE stock logo
AEXAY
Atos
N/A
ANA Holdings Inc. stock logo
ALNPY
ANA
N/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
N/A
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc stock logo
ACBFF
Aurora Cannabis
N/A960.96 millionN/ANot Optionable
Atos SE stock logo
AEXAY
Atos
95,140557.20 millionN/ANot Optionable
ANA Holdings Inc. stock logo
ALNPY
ANA
40,507N/AN/ANot Optionable
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
2,802530.49 millionN/ANot Optionable
Hikma Pharmaceuticals PLC stock logo
HKMPF
Hikma Pharmaceuticals
8,800220.23 millionN/ANot Optionable

BKGFY, HKMPF, ALNPY, ACBFF, and AEXAY Headlines

SourceHeadline
Hikma Pharmaceuticals PLC goes ex dividend tomorrowHikma Pharmaceuticals PLC goes ex dividend tomorrow
msn.com - March 20 at 5:15 AM
Optimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past weekOptimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past week
finance.yahoo.com - March 18 at 7:54 AM
Hikma Pharmaceuticals PLC (HKMPF)Hikma Pharmaceuticals PLC (HKMPF)
finance.yahoo.com - February 27 at 4:02 PM
Drugmaker Hikma expects profit to be slightly lower in 2024Drugmaker Hikma expects profit to be slightly lower in 2024
msn.com - February 22 at 7:56 AM
Hikma Pharma FY Profit IncreasesHikma Pharma FY Profit Increases
markets.businessinsider.com - February 22 at 7:56 AM
Hikma divi boost sends stock 5% higherHikma divi boost sends stock 5% higher
proactiveinvestors.co.uk - February 22 at 3:52 AM
Hikma Pharma introduces Combogesic IV injection in USHikma Pharma introduces Combogesic IV injection in US
pharmabiz.com - February 6 at 7:57 AM
Hikma Pharmaceuticals: Notice of ResultsHikma Pharmaceuticals: Notice of Results
cbonds.com - February 6 at 7:57 AM
Hikma Pharmaceuticals did not report suspicious opioid orders for 15 years, NC Attorney General Josh Stein saysHikma Pharmaceuticals did not report suspicious opioid orders for 15 years, NC Attorney General Josh Stein says
msn.com - February 1 at 6:51 PM
Hikma Pharmaceuticals Agrees in Principle to Pay up to $115M in US Opioid SettlementHikma Pharmaceuticals Agrees in Principle to Pay up to $115M in US Opioid Settlement
marketwatch.com - February 1 at 1:51 PM
Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 millionAd firm Publicis, drugmaker Hikma settle US opioid cases for $500 million
finance.yahoo.com - February 1 at 1:51 PM
UPDATE 1-Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 millionUPDATE 1-Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 million
finance.yahoo.com - February 1 at 1:51 PM
Hikma Pharmaceuticals PLCs (LON:HIK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?Hikma Pharmaceuticals PLC's (LON:HIK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
finance.yahoo.com - January 29 at 9:27 AM
Hikma Pharmaceuticals: Company Secretary ChangeHikma Pharmaceuticals: Company Secretary Change
cbonds.com - December 30 at 8:41 AM
FTSE 100 Live: Stocks close subdued session little changedFTSE 100 Live: Stocks close subdued session little changed
proactiveinvestors.co.uk - November 7 at 12:18 PM
FTSE 100 Live: Stocks soar on hopes interest rates have peakedFTSE 100 Live: Stocks soar on hopes interest rates have peaked
proactiveinvestors.co.uk - November 2 at 1:47 PM
The one-year decline in earnings might be taking its toll on Hikma Pharmaceuticals (LON:HIK) shareholders as stock falls 3.3% over the past weekThe one-year decline in earnings might be taking its toll on Hikma Pharmaceuticals (LON:HIK) shareholders as stock falls 3.3% over the past week
finance.yahoo.com - October 5 at 11:59 AM
Stocks Open Lower, Weighed Down by Rising Bond YieldsStocks Open Lower, Weighed Down by Rising Bond Yields
finance.yahoo.com - October 3 at 10:37 AM
Rakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North AfricaRakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North Africa
finance.yahoo.com - August 10 at 9:17 AM
Hikma Appoints Bill Larkins as President of Injectables BusinessHikma Appoints Bill Larkins as President of Injectables Business
marketwatch.com - August 9 at 4:33 AM
Hikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseasesHikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseases
finance.yahoo.com - July 26 at 4:38 PM
Selling Hikma Pharmaceuticals After A 40% Share Price Gain In 7 MonthsSelling Hikma Pharmaceuticals After A 40% Share Price Gain In 7 Months
msn.com - May 6 at 10:01 AM
Riad Mishlawi to become CEO of Hikma PharmaRiad Mishlawi to become CEO of Hikma Pharma
medicaldialogues.in - April 13 at 10:36 AM
Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceuticals PLCRiad Mishlawi named Chief Executive Officer of Hikma Pharmaceuticals PLC
jordantimes.com - April 12 at 6:46 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aurora Cannabis logo

Aurora Cannabis

OTCMKTS:ACBFF
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in more than 10 countries worldwide.
Atos logo

Atos

OTCMKTS:AEXAY
Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, and telecommunication and media industries. The company was incorporated in 1982 and is headquartered in Bezons, France.
ANA logo

ANA

OTCMKTS:ALNPY
ANA Holdings Inc., together with its subsidiaries, provides air transportation services in Japan and internationally. It operates through Air Transportation, Aviation-Related Business, Travel Business, and Trading Business segments. The Air Transportation segment offers regular and irregular air transport of passengers, cargo, etc. on domestic and international routes. The Aviation-Related Business segment provides services incidental to air transportation, such as airport handling and maintenance. The Travel Business develops and sells travel products, as well as plans and sells package travel products. The Trading Business imports and exports aviation-related materials, as well as sells through stores and mail-order channels. The company was formerly known as All Nippon Airways Co., Ltd. and changed its name to ANA Holdings Inc. in April 2013. ANA Holdings Inc. was incorporated in 1920 and is headquartered in Minato, Japan.
The Berkeley Group logo

The Berkeley Group

OTCMKTS:BKGFY
The Berkeley Group Holdings plc, together with its subsidiaries, engages in the residential-led and mixed-use property development and ancillary activities in the United Kingdom. The company is involved in land selling activities. It operates under the Berkeley, St Edward, St George, St James, St Joseph, and St William brand names. The Berkeley Group Holdings plc was founded in 1976 and is headquartered in Cobham, the United Kingdom.
Hikma Pharmaceuticals logo

Hikma Pharmaceuticals

OTCMKTS:HKMPF
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.